PMID- 16797051 OWN - NLM STAT- MEDLINE DCOM- 20061010 LR - 20191210 IS - 0042-6822 (Print) IS - 0042-6822 (Linking) VI - 353 IP - 1 DP - 2006 Sep 15 TI - Receptor use by pathogenic arenaviruses. PG - 111-20 AB - The arenavirus family contains several important human pathogens including Lassa fever virus (LASV), lymphocytic choriomeningitis virus (LCMV) and the New World clade B viruses Junin (JUNV) and Machupo (MACV). Previously, alpha-dystroglycan (alpha-DG) was identified as a receptor recognized by LASV and certain strains of LCMV. However, other studies have suggested that alpha-DG is probably not used by the clade B viruses, and the receptor(s) for these pathogens is currently unknown. Using pseudotyped retroviral vectors displaying arenavirus glycoproteins (GPs), we are able to explore the role played by the GP in viral entry in the absence of other viral proteins. By examining the ability of the vectors to transduce DG knockout murine embryonic stem (ES) cells, we have confirmed that LASV has an absolute requirement for alpha-DG in these cells. However, the LCMV GP can still direct substantial entry into murine ES cells in the absence of alpha-DG, even when the GP from the clone 13 variant is used that has previously been reported to be highly dependent on alpha-DG for entry. We also found that neither LASV or LCMV pseudotyped vectors were able to transduce human or murine lymphocytes, presumably due to the glycosylation state of alpha-DG in these cells. In contrast, the JUNV and MACV GPs displayed broad tropism on human, murine and avian cell types, including lymphocytes, and showed no requirement for alpha-DG in murine ES cells. These findings highlight the importance of molecules other than alpha-DG for arenavirus entry. An alternate receptor is present on murine ES cells that can be used by LCMV but not by LASV, and which is not available on human or murine lymphocytes, while a distinct and widely expressed receptor(s) is used by the clade B viruses. FAU - Reignier, Therese AU - Reignier T AD - Saban Research Institute of Children's Hospital Los Angeles, Los Angeles, CA 90027, USA. FAU - Oldenburg, Jill AU - Oldenburg J FAU - Noble, Beth AU - Noble B FAU - Lamb, Erika AU - Lamb E FAU - Romanowski, Victor AU - Romanowski V FAU - Buchmeier, Michael J AU - Buchmeier MJ FAU - Cannon, Paula M AU - Cannon PM LA - eng GR - AI055720/AI/NIAID NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060621 PL - United States TA - Virology JT - Virology JID - 0110674 RN - 0 (Receptors, Cell Surface) RN - 0 (Receptors, Virus) SB - IM MH - Animals MH - Arenaviridae/classification/*pathogenicity MH - CHO Cells MH - COS Cells MH - Cell Culture Techniques MH - Cell Line MH - Chlorocebus aethiops MH - Cricetinae MH - HeLa Cells MH - Humans MH - Jurkat Cells MH - Mice MH - NIH 3T3 Cells MH - Receptors, Cell Surface/*metabolism MH - Receptors, Virus/*metabolism MH - Stem Cells/*cytology MH - Vero Cells EDAT- 2006/06/27 09:00 MHDA- 2006/10/13 09:00 CRDT- 2006/06/27 09:00 PHST- 2006/03/02 00:00 [received] PHST- 2006/04/11 00:00 [revised] PHST- 2006/05/12 00:00 [accepted] PHST- 2006/06/27 09:00 [pubmed] PHST- 2006/10/13 09:00 [medline] PHST- 2006/06/27 09:00 [entrez] AID - S0042-6822(06)00337-0 [pii] AID - 10.1016/j.virol.2006.05.018 [doi] PST - ppublish SO - Virology. 2006 Sep 15;353(1):111-20. doi: 10.1016/j.virol.2006.05.018. Epub 2006 Jun 21.